242 related articles for article (PubMed ID: 17826781)
1. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
Mausner-Fainberg K; Luboshits G; Mor A; Maysel-Auslender S; Rubinstein A; Keren G; George J
Atherosclerosis; 2008 Apr; 197(2):829-39. PubMed ID: 17826781
[TBL] [Abstract][Full Text] [Related]
2. Toward a role for statins in immunomodulation.
Mach F
Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
5. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
8. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
[TBL] [Abstract][Full Text] [Related]
9. Graft protective effects and donor-specific antibody suppression by CD4
Iguchi K; Yamamoto Y; Uchiyama M; Masaoka H; Nakamura M; Shizuka H; Imazuru T; Shimokawa T
J Cardiothorac Surg; 2024 Jun; 19(1):368. PubMed ID: 38918849
[TBL] [Abstract][Full Text] [Related]
10. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
Meier P; Meier R; Blanc E
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
[TBL] [Abstract][Full Text] [Related]
11. Changes of naturally occurring CD4(+)CD25(+) FOXP3(+) regulatory T cells in patients with acute coronary syndrome and the beneficial effects of atorvastatin treatment.
Wang ZX; Wang CQ; Li XY; Ding Y; Feng GK; Jiang XJ
Int Heart J; 2015; 56(2):163-9. PubMed ID: 25740578
[TBL] [Abstract][Full Text] [Related]
12. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
[TBL] [Abstract][Full Text] [Related]
14. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
[TBL] [Abstract][Full Text] [Related]
16. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
18. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
19. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
20. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
